Related references
Note: Only part of the references are listed.Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli
Luigia Scudeller et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Advances in the therapy of bacterial bloodstream infections
M. Giannella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its Sell-By Date in an Era of New Antibiotics and Regional Carbapenemase Epidemiology
David M. Livermore et al.
CLINICAL INFECTIOUS DISEASES (2020)
Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments
P. Wistrand-Yuen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection
Sheng Bi et al.
INFECTION (2019)
Interplay between β-lactamases and new β-lactamase inhibitors
Karen Bush et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Synergy effect of meropenem- based combinations against Acinetobacter baumannii: a systematic review and meta-analysis
Zhihui Jiang et al.
INFECTION AND DRUG RESISTANCE (2018)
Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model
Yiying Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae
Laurent Poirel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B
Yiying Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Clinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections
Bingxuan Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae
A. Oliva et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Synergistic combinations of polymyxins
Justin R. Lenhard et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Polymyxin: Alternative Mechanisms of Action and Resistance
Michael J. Trimble et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Safety of high-dose doripenem in adult patients with cystic fibrosis
Seth Strawbridge et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2016)
Structural Basis for Carbapenem-Hydrolyzing Mechanisms of Carbapenemases Conferring Antibiotic Resistance
Jeong Ho Jeon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Polymyxin B with dual carbapenem combination therapy against carbapenemase-producing Klebsiella pneumoniae
Nathalie Grace Chua et al.
JOURNAL OF INFECTION (2015)
Doripenem MICs and ompK36 Porin Genotypes of Sequence Type 258, KPC-Producing Klebsiella pneumoniae May Predict Responses to Carbapenem-Colistin Combination Therapy among Patients with Bacteremia
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
Oren Zusman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Zakuan Z. Deris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae
Meredith G. Jernigan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparative Effects of Carbapenems on Bacterial Load and Host Immune Response in a Klebsiella pneumoniae Murine Pneumonia Model
Jamese J. Hilliard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Catharine C. Bulik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay
Spyros Pournaras et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Progress and Challenges in Implementing the Research on ESKAPE Pathogens
Louis B. Rice
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Share Paper
